Hyperammonemia Alters the Function of AMPA and NMDA Receptors in Hippocampus: Extracellular CGMP Reverses Some of These Alterations

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2022 Apr 7

PMID 35386048

Authors

Maria Sancho-Alonso

Lucas Taoro-Gonzalez

Andrea Cabrera-Pastor

Vicente Felipo

Vicent Teruel-Marti

Affiliations

Soon will be listed here.

Abstract

Chronic hyperammonemia alters membrane expression of AMPA and NMDA receptors subunits in hippocampus leading to impaired memory and learning. Increasing extracellular cGMP normalizes these alterations. However, it has not been studied whether hyperammonemia alters the function of AMPA and NMDA receptors. The aims of this work were: (1) assess if hyperammonemia alters AMPA and NMDA receptors function; (2) analyze if extracellular cGMP reverses these alterations. A multielectrode array device was used to stimulate Schäffer collaterals and record postsynaptic currents in the CA1 region in hippocampal slices from control and hyperammonemic rats and analyze different features of the excitatory postsynaptic potentials. Hyperammonemia reduces the amplitude and delays appearance of AMPA EPSPs, whereas increases amplitude, hyperpolarization, depolarization and desensitization area of the NMDA EPSPs. These alterations in AMPA and NMDA function are accentuated as the stimulation intensity increases. Adding extracellular cGMP reverses the alteration in amplitude in both, AMPA and NMDA EPSPs. In control slices extracellular cGMP decreases the AMPA and NMDA EPSPs amplitude and delays the response of neurons and the return to the resting potential at all stimulation intensities. In conclusion, hyperammonemia decreases the AMPA response, whereas increases the NMDA response and extracellular cGMP reverses these alterations.

Citing Articles

Ammonia and beyond - biomarkers of hepatic encephalopathy.

Gallego J, Ballester M, Fiorillo A, Casanova-Ferrer F, Lopez-Gramaje A, Urios A Metab Brain Dis. 2025; 40(1):100.

PMID: 39812958 PMC: 11735499. DOI: 10.1007/s11011-024-01512-7.

Ammonium chloride reduces excitatory synaptic transmission onto CA1 pyramidal neurons of mouse organotypic slice cultures.

Kleidonas D, Hilfiger L, Lenz M, Haussinger D, Vlachos A Front Cell Neurosci. 2024; 18:1410275.

PMID: 39411004 PMC: 11473415. DOI: 10.3389/fncel.2024.1410275.

Implications of Kynurenine Pathway Metabolism for the Immune System, Hypothalamic-Pituitary-Adrenal Axis, and Neurotransmission in Alcohol Use Disorder.

Osuch B, Misztal T, Palatynska K, Tomaszewska-Zaremba D Int J Mol Sci. 2024; 25(9).

PMID: 38732064 PMC: 11084367. DOI: 10.3390/ijms25094845.

Preface for the Vicente Felipo Honorary Issue of Neurochemical Research.

Llansola M Neurochem Res. 2024; 49(6):1421-1426.

PMID: 38641758 DOI: 10.1007/s11064-024-04139-3.

Enhanced recruitment of glutamate receptors underlies excitotoxicity of mitral cells in acute hyperammonemia.

Li M, Liu Z, Lai K, Liu H, Gong L, Shi H Front Cell Neurosci. 2022; 16:1002671.

PMID: 36385944 PMC: 9651449. DOI: 10.3389/fncel.2022.1002671.

References

Felipo V, Butterworth R . Neurobiology of ammonia. Prog Neurobiol. 2002; 67(4):259-79. DOI: 10.1016/s0301-0082(02)00019-9. View

Felipo V . Hepatic encephalopathy: effects of liver failure on brain function. Nat Rev Neurosci. 2013; 14(12):851-8. DOI: 10.1038/nrn3587. View

Felipo V, Ordono J, Urios A, El Mlili N, Gimenez-Garzo C, Aguado C . Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests. Hepatology. 2011; 55(2):530-9. DOI: 10.1002/hep.24704. View

Cabrera-Pastor A, Arenas Y, Taoro-Gonzalez L, Montoliu C, Felipo V . Chronic hyperammonemia alters extracellular glutamate, glutamine and GABA and membrane expression of their transporters in rat cerebellum. Modulation by extracellular cGMP. Neuropharmacology. 2019; 161:107496. DOI: 10.1016/j.neuropharm.2019.01.011. View

Cauli O, Rodrigo R, Llansola M, Montoliu C, Monfort P, Piedrafita B . Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab Brain Dis. 2008; 24(1):69-80. DOI: 10.1007/s11011-008-9115-4. View

Llansola M, Montoliu C, Cauli O, Hernandez-Rabaza V, Agusti A, Cabrera-Pastor A . Chronic hyperammonemia, glutamatergic neurotransmission and neurological alterations. Metab Brain Dis. 2012; 28(2):151-4. DOI: 10.1007/s11011-012-9337-3. View

Cabrera-Pastor A, Malaguarnera M, Taoro-Gonzalez L, Llansola M, Felipo V . Extracellular cGMP Modulates Learning Biphasically by Modulating Glycine Receptors, CaMKII and Glutamate-Nitric Oxide-cGMP Pathway. Sci Rep. 2016; 6:33124. PMC: 5025658. DOI: 10.1038/srep33124. View

Taoro-Gonzalez L, Cabrera-Pastor A, Sancho-Alonso M, Arenas Y, Meseguer-Estornell F, Balzano T . Differential role of interleukin-1β in neuroinflammation-induced impairment of spatial and nonspatial memory in hyperammonemic rats. FASEB J. 2019; 33(9):9913-9928. DOI: 10.1096/fj.201900230RR. View

Monfort P, Munoz M, Felipo V . Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia. Metab Brain Dis. 2005; 20(4):265-74. DOI: 10.1007/s11011-005-7905-5. View

10.

Monfort P, Munoz M, Elayadi A, Kosenko E, Felipo V . Effects of hyperammonemia and liver failure on glutamatergic neurotransmission. Metab Brain Dis. 2003; 17(4):237-50. DOI: 10.1023/a:1021993431443. View

11.

Erceg S, Monfort P, Hernandez-Viadel M, Llansola M, Montoliu C, Felipo V . Restoration of learning ability in hyperammonemic rats by increasing extracellular cGMP in brain. Brain Res. 2005; 1036(1-2):115-21. DOI: 10.1016/j.brainres.2004.12.045. View

12.

Erceg S, Monfort P, Hernandez-Viadel M, Rodrigo R, Montoliu C, Felipo V . Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology. 2005; 41(2):299-306. DOI: 10.1002/hep.20565. View

13.

Taoro-Gonzalez L, Arenas Y, Cabrera-Pastor A, Felipo V . Extracellular cGMP Reverses Altered Membrane Expression of AMPA Receptors in Hippocampus of Hyperammonemic Rats: Underlying Mechanisms. Mol Neurobiol. 2018; 56(6):4428-4439. DOI: 10.1007/s12035-018-1387-z. View

14.

Anggono V, Huganir R . Regulation of AMPA receptor trafficking and synaptic plasticity. Curr Opin Neurobiol. 2012; 22(3):461-9. PMC: 3392447. DOI: 10.1016/j.conb.2011.12.006. View

15.

Richter-Levin G, Canevari L, Bliss T . Long-term potentiation and glutamate release in the dentate gyrus: links to spatial learning. Behav Brain Res. 1995; 66(1-2):37-40. DOI: 10.1016/0166-4328(94)00121-u. View

16.

Monfort P, Munoz M, Kosenko E, Felipo V . Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase. J Neurosci. 2002; 22(23):10116-22. PMC: 6758733. View

17.

Munoz M, Monfort P, Gaztelu J, Felipo V . Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in vitro. Neurochem Res. 2000; 25(4):437-41. DOI: 10.1023/a:1007547622844. View

18.

Sheng M, Cummings J, ROLDAN L, Jan Y, Jan L . Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature. 1994; 368(6467):144-7. DOI: 10.1038/368144a0. View

19.

Wenthold R, Petralia R, Blahos J I, Niedzielski A . Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci. 1996; 16(6):1982-9. PMC: 6578515. View

20.

Coombs I, Cull-Candy S . Transmembrane AMPA receptor regulatory proteins and AMPA receptor function in the cerebellum. Neuroscience. 2009; 162(3):656-65. PMC: 3217091. DOI: 10.1016/j.neuroscience.2009.01.004. View